154 related articles for article (PubMed ID: 10741939)
1. Cyclo-oxygenase-2 inhibitors ameliorate the severity of experimental colitis in rats.
Karmeli F; Cohen P; Rachmilewitz D
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):223-31. PubMed ID: 10741939
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
[TBL] [Abstract][Full Text] [Related]
3. Effect of nimesulide on acetic acid- and leukotriene-induced inflammatory bowel disease in rats.
Singh VP; Patil CS; Jain NK; Singh A; Kulkarni SK
Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):163-75. PubMed ID: 14518559
[TBL] [Abstract][Full Text] [Related]
4. Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats.
Dong WG; Liu SP; Yu BP; Wu DF; Luo HS; Yu JP
World J Gastroenterol; 2003 Nov; 9(11):2533-8. PubMed ID: 14606091
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of endogenous nitric oxide activity impairs the colonic sparing effect of rofecoxib, the cyclooxygenase-2 inhibitor and resveratrol, the preferential cyclooxygenase-1 inhibitor in the course of experimental colitis. Role of oxidative stress biomarkers and proinflammatory cytokines.
Kwiecień S; Wojcik-Grzybek D; Sliwowski Z; Targosz A; Chmura A; Magierowska K; Strzalka M; Glowacka U; Ptak-Belowska A; Magierowski M; Brzozowski T
J Physiol Pharmacol; 2023 Oct; 74(5):. PubMed ID: 38085520
[TBL] [Abstract][Full Text] [Related]
6. FR167653, a potent suppressant of interleukin-1 and tumor necrosis factor-alpha production, ameliorates colonic lesions in experimentally induced acute colitis.
Blandino II; Otaka M; Jin M; Komatsu K; Odashima M; Konishi N; Sato T; Kato S; Watanabe S
J Gastroenterol Hepatol; 2001 Oct; 16(10):1105-11. PubMed ID: 11686836
[TBL] [Abstract][Full Text] [Related]
7. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis.
Zwolinska-Wcislo M; Brzozowski T; Ptak-Belowska A; Targosz A; Urbanczyk K; Kwiecien S; Sliwowski Z
World J Gastroenterol; 2011 Sep; 17(36):4076-89. PubMed ID: 22039321
[TBL] [Abstract][Full Text] [Related]
9. Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats.
Ablin J; Shalev O; Okon E; Karmeli F; Rachmilewitz D
Inflamm Bowel Dis; 1999 Nov; 5(4):253-61. PubMed ID: 10579118
[TBL] [Abstract][Full Text] [Related]
10. Acetic acid-derived prostaglandin-dependent colonic adaptive cytoprotection is preserved in chronic colitis: role of cyclo-oxygenase.
Ohara K; Kono T; Chisato N; Asama T; Yoneda M; Kasai S
Int J Colorectal Dis; 2003 May; 18(3):260-6. PubMed ID: 12673493
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats.
Cuzzocrea S; Mazzon E; Serraino I; Dugo L; Centorrino T; Ciccolo A; Sautebin L; Caputi AP
Eur J Pharmacol; 2001 Nov; 431(1):91-102. PubMed ID: 11716847
[TBL] [Abstract][Full Text] [Related]
12. Dual effect of chronic nicotine administration: augmentation of jejunitis and amelioration of colitis induced by iodoacetamide in rats.
Eliakim R; Karmeli F; Cohen P; Heyman SN; Rachmilewitz D
Int J Colorectal Dis; 2001 Feb; 16(1):14-21. PubMed ID: 11317692
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
[TBL] [Abstract][Full Text] [Related]
15. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation.
Wallace JL; Chapman K; McKnight W
Br J Pharmacol; 1999 Mar; 126(5):1200-4. PubMed ID: 10205009
[TBL] [Abstract][Full Text] [Related]
16. Hyperbaric oxygen: a novel modality to ameliorate experimental colitis.
Rachmilewitz D; Karmeli F; Okon E; Rubenstein I; Better OS
Gut; 1998 Oct; 43(4):512-8. PubMed ID: 9824579
[TBL] [Abstract][Full Text] [Related]
17. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
Rachmilewitz D; Karmeli F; Okon E; Bursztyn M
Gut; 1995 Aug; 37(2):247-55. PubMed ID: 7557576
[TBL] [Abstract][Full Text] [Related]
18. Variable response to probiotics in two models of experimental colitis in rats.
Shibolet O; Karmeli F; Eliakim R; Swennen E; Brigidi P; Gionchetti P; Campieri M; Morgenstern S; Rachmilewitz D
Inflamm Bowel Dis; 2002 Nov; 8(6):399-406. PubMed ID: 12454615
[TBL] [Abstract][Full Text] [Related]
19. Sulphydryl blocker-induced rat colitis is ameliorated by intravenous injection of antibody to colonic surfactant-like particle.
Eliakim R; Karmeli F; Cohen P; Rachmilewitz D; Shao JS; Alpers DH
Inflamm Bowel Dis; 1999 Feb; 5(1):16-23. PubMed ID: 10028445
[TBL] [Abstract][Full Text] [Related]
20. Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats.
Okayama M; Hayashi S; Aoi Y; Nishio H; Kato S; Takeuchi K
Dig Dis Sci; 2007 Sep; 52(9):2095-103. PubMed ID: 17429720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
